Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.020
Buy
RSI(14)
53.185
Neutral
STOCH(KDJ)(9,3,3)
64.764
Neutral
ATR(14)
4.621
Low Volatility
CCI(14)
161.153
Buy
Williams %R
45.075
Neutral
TRIX(12,20)
0.016
Sell
StochRSI(14)
48.482
Sell
Search
GeneDx Holdings Corp
WGSAdd to Watchlist
65.110USD
-3.850-5.58%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.93BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-5.58%
5 Days
+10.17%
1 Month
-9.20%
6 Months
-32.36%
Year to Date
-49.94%
1 Year
-35.92%
Key Figures
69.920Open
70.830High
885.76KVolume
LossP/E TTM
52.14P/E Dynamic
--Dividend TTM
2.99%Turnover Ratio
68.960Prev. Close
64.880Low
48.57MTurnover
LossP/E Static
7.60P/B
0.00%Div Yield TTM
-16.33%ROA
170.87052wk High
1.09Volume Ratio
-52.29MNet Profit
29.67MShares
-2.6604EPS TTM
1.99Beta
-30.42%ROE
32.21052wk Low
8.63%Amplitude
66.71%Gross Margin
1.93BMarket Cap
0.03Reward/Risk
4.06%Risk Rate
TradingKey Stock Score of GeneDx Holdings Corp
Currency: USD Updated: 2026-07-31Key Insights
GeneDx Holdings Corp's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 11 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 92.89.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
GeneDx Holdings Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
GeneDx Holdings Corp Highlights
StrengthsRisks
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 111.06% year-on-year.
Undervalued
The company’s latest PE is -24.47, at a low 3-year percentile range.
Held by Catherine Wood
Star Investor Catherine Wood holds 1.76M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.21.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
92.889
Target Price
+42.66%
Upside Space
GeneDx Holdings Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
9
analysts
Buy
Current Rating
92.889
Target Price
+42.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
58
Total
9
Median
10
Average
Company name
Ratings
Analysts
GeneDx Holdings Corp
WGS
9
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Indicators
Moving Average
Indicators
Value
Direction
MA5
64.035
Buy
MA10
62.755
Buy
MA20
64.005
Buy
MA50
59.983
Buy
MA100
60.867
Buy
MA200
91.038
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
GeneDx Holdings Corp Info
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Ticker SymbolWGS
CompanyGeneDx Holdings Corp
CEOStueland (Katherine A)
Websitehttps://sema4.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52717.700
+339.700 (+0.65%)
28503.700
+342.800 (+1.22%)
7527.800
+52.700 (+0.70%)
14791.000
+42.000 (+0.28%)
63264.000
+412.000 (+0.66%)
6397.000
+31.600 (+0.50%)
79.492
-6.442 (-7.50%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4068.630
+27.200 (+0.67%)
FAQs
What is the current price of GeneDx Holdings Corp (WGS)?
The current price of GeneDx Holdings Corp (WGS) is 65.11.
What is the symbol of GeneDx Holdings Corp?
The ticker symbol of GeneDx Holdings Corp is WGS.
What is the 52-week high of GeneDx Holdings Corp?
The 52-week high of GeneDx Holdings Corp is 170.87.
What is the 52-week low of GeneDx Holdings Corp?
The 52-week low of GeneDx Holdings Corp is 32.21.
What is the market capitalization of GeneDx Holdings Corp?
The market capitalization of GeneDx Holdings Corp is 1.93B.
Is GeneDx Holdings Corp (WGS) currently rated as Buy, Hold, or Sell?
According to analysts, GeneDx Holdings Corp (WGS) has an overall rating of Buy, with a price target of 92.89.
What is the Earnings Per Share (EPS TTM) of GeneDx Holdings Corp (WGS)?
The Earnings Per Share (EPS TTM) of GeneDx Holdings Corp (WGS) is -0.73.